Send feedback

VSX2 p.Pro348=

c.1044G>A · rs747657718 · VCV1589196

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0175%, mid)
Conditions
1
isolated microphthalmia 2

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -7.4GERP -4.4
Overall
CADD0.565PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0175% Middle Eastern · 1/5,700 alleles
Filtering AF 0.000127% ClinGen BA1/BS1 input FAF95, joint · FAF99 9.2e-05%
Overall 0.000636% 9/1,414,204 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0175% 5,700
Admixed American 0.00189% 52,950
Remaining individualsnot grpmax-eligible 0.00165% 60,744
South Asian 0.00118% 84,992
European (non-Finnish) 0.000432% 231,260

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
VSX2
Protein
p.Pro348=
Coding
c.1044G>A
MANE Select
NM_182894
dbSNP
rs747657718
Type
single nucleotide variant
Location
chr14:74260877 (GRCh38)
Gene constraint
LOEUF 1.35 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 61.65
Residue 348
the 'disordered' region
Full VSX2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/vsx2-p-pro348 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown